377 research outputs found

    Alien Registration- Sevigny, J. Leo (Mexico, Oxford County)

    Get PDF
    https://digitalmaine.com/alien_docs/18006/thumbnail.jp

    Marshall system for aerospace simulation (MARSYAS)

    Get PDF
    System is simple flexible language which can be coded by users unfamiliar with computer programming. It is designed for engineers with little experience in simulation, who desire to simulate large physical systems. User has ability to mix differential equations with diagrams in his model. With few exceptions, there is no rigid statement-operator structure within given module

    Preliminary Technology Maturation Plan for Immobilization of High-Level Waste in Glass Ceramics

    Get PDF
    A technology maturation plan (TMP) was developed for immobilization of high-level waste (HLW) raffinate in a glass ceramics waste form using a cold-crucible induction melter (CCIM). The TMP was prepared by the following process: 1) define the reference process and boundaries of the technology being matured, 2) evaluate the technology elements and identify the critical technology elements (CTE), 3) identify the technology readiness level (TRL) of each of the CTE’s using the DOE G 413.3-4, 4) describe the development and demonstration activities required to advance the TRLs to 4 and 6 in order, and 5) prepare a preliminary plan to conduct the development and demonstration. Results of the technology readiness assessment identified five CTE’s and found relatively low TRL’s for each of them: • Mixing, sampling, and analysis of waste slurry and melter feed: TRL-1 • Feeding, melting, and pouring: TRL-1 • Glass ceramic formulation: TRL-1 • Canister cooling and crystallization: TRL-1 • Canister decontamination: TRL-4 Although the TRL’s are low for most of these CTE’s (TRL-1), the effort required to advance them to higher values. The activities required to advance the TRL’s are listed below: • Complete this TMP • Perform a preliminary engineering study • Characterize, estimate, and simulate waste to be treated • Laboratory scale glass ceramic testing • Melter and off-gas testing with simulants • Test the mixing, sampling, and analyses • Canister testing • Decontamination system testing • Issue a requirements document • Issue a risk management document • Complete preliminary design • Integrated pilot testing • Issue a waste compliance plan A preliminary schedule and budget were developed to complete these activities as summarized in the following table (assuming 2012 dollars). TRL Budget Year MSA FMP GCF CCC CD Overall $M 2012 1 1 1 1 4 1 0.3 2013 2 2 1 1 4 1 1.3 2014 2 3 1 1 4 1 1.8 2015 2 3 2 2 4 2 2.6 2016 2 3 2 2 4 2 4.9 2017 2 3 3 2 4 2 9.8 2018 3 3 3 3 4 3 7.9 2019 3 3 3 3 4 3 5.1 2020 3 3 3 3 4 3 14.6 2021 3 3 3 3 4 3 7.3 2022 3 3 3 3 4 3 8.8 2023 4 4 4 4 4 4 9.1 2024 5 5 5 5 5 5 6.9 2025 6 6 6 6 6 6 6.9 CCC = canister cooling and crystallization; FMP = feeding, melting, and pouring; GCF = glass ceramic formulation; MSA = mixing, sampling, and analyses. This TMP is intended to guide the development of the glass ceramics waste form and process to the point where it is ready for industrialization

    Identification of a Human Monoclonal Antibody to Replace Equine Diphtheria Anti-toxin for the Treatment of Diphtheria

    Get PDF
    Diphtheria anti-toxin (DAT) has been used to treat Corynebacterium diphtheriae infection for over one hundred years. While the global incidence of diphtheria has declined in the 20th century, the disease remains endemic in many parts of the world and significant outbreaks still occur. Diphtheria anti-toxin is an equine polyclonal antibody with considerable side effects that is in critically short supply globally. A safer, more readily available alternative to DAT would be desirable. In the current study, we cloned human monoclonal antibodies (HuMabs) directly from antibody secreting cells of human volunteers immunized with Td vaccine. We isolated a diverse panel of HuMabs that recognized diphtheria toxoid and recombinant protein fragments of diphtheria toxin. Forty-one unique HuMabs were expressed in 293T cells and tested for neutralization of diphtheria toxin in in vitro cytotoxicity assays. The lead candidate HuMab, 315C4 potently neutralized diphtheria toxin with an EC50 of 0.65 ng/mL. Additionally, 25 μg of 315C4 completely protected guinea pigs in an in vivo lethality model. In comparison, 1.6 IU of DAT was necessary for full protection resulting in an estimated relative potency of 64 IU/mg for 315C4. We further established that our lead candidate HuMab binds to the receptor binding domain of diphtheria toxin and blocks the toxin from binding to the putative receptor, heparin binding-epidermal growth factor like growth factor. The discovery of a specific and potent neutralizing antibody against diphtheria toxin holds promise as a potential human therapeutic and is being developed for human use

    Iron Phosphate Glass-Containing Hanford Waste Simulant

    Full text link
    Resolution of the nation’s high level tank waste legacy requires the design, construction, and operation of large and technically complex one-of-a-kind processing waste treatment and vitrification facilities. While the ultimate limits for waste loading and melter efficiency have yet to be defined or realized, significant reductions in glass volumes for disposal and mission life may be possible with advancements in melter technologies and/or glass formulations. This test report describes the experimental results from a small-scale test using the research scale melter (RSM) at Pacific Northwest National Laboratory (PNNL) to demonstrate the viability of iron phosphate-based glass with a selected waste composition that is high in sulfates (4.37 wt% SO3). The primary objective of the test was to develop data to support a cost-benefit analysis as related to the implementation of phosphate-based glasses for Hanford low activity waste (LAW) and/or other high-level waste streams within the U.S. Department of Energy complex. The testing was performed by PNNL and supported by Idaho National Laboratory, Savannah River National Laboratory, and Mo-Sci Corporation

    GANDALF: Generative Adversarial Networks with Discriminator-Adaptive Loss Fine-tuning for Alzheimer's Disease Diagnosis from MRI

    Full text link
    Positron Emission Tomography (PET) is now regarded as the gold standard for the diagnosis of Alzheimer's Disease (AD). However, PET imaging can be prohibitive in terms of cost and planning, and is also among the imaging techniques with the highest dosage of radiation. Magnetic Resonance Imaging (MRI), in contrast, is more widely available and provides more flexibility when setting the desired image resolution. Unfortunately, the diagnosis of AD using MRI is difficult due to the very subtle physiological differences between healthy and AD subjects visible on MRI. As a result, many attempts have been made to synthesize PET images from MR images using generative adversarial networks (GANs) in the interest of enabling the diagnosis of AD from MR. Existing work on PET synthesis from MRI has largely focused on Conditional GANs, where MR images are used to generate PET images and subsequently used for AD diagnosis. There is no end-to-end training goal. This paper proposes an alternative approach to the aforementioned, where AD diagnosis is incorporated in the GAN training objective to achieve the best AD classification performance. Different GAN lossesare fine-tuned based on the discriminator performance, and the overall training is stabilized. The proposed network architecture and training regime show state-of-the-art performance for three- and four- class AD classification tasks.Comment: Accepted for publication at the MICCAI 2020 conferenc
    corecore